| Philip Astley-Sparke |
REPL |
Common Stock |
Gift |
-1.78% |
|
|
-25,000 |
1,380,071 |
18 Feb 2026 |
Direct |
| Sushil Patel |
REPL |
Common Stock |
Award |
60% |
|
|
200,000 |
533,576 |
19 Dec 2025 |
Direct |
| Konstantinos Xynos |
REPL |
Common Stock |
Award |
43% |
|
|
60,000 |
199,685 |
19 Dec 2025 |
Direct |
| Emily Luisa Hill |
REPL |
Common Stock |
Award |
44.6% |
|
|
60,000 |
194,368 |
19 Dec 2025 |
Direct |
| Christopher Sarchi |
REPL |
Common Stock |
Award |
28.4% |
|
|
35,000 |
158,088 |
19 Dec 2025 |
Direct |
| Andrew Schwendenman |
REPL |
Common Stock |
Award |
14.6% |
|
|
10,000 |
78,284 |
19 Dec 2025 |
Direct |
| Kapil Dhingra |
REPL |
Common Stock |
Sale |
-100% |
$32,958 |
$10.40 |
-3,169 |
0 |
09 Dec 2025 |
Direct |
| Kapil Dhingra |
REPL |
Common Stock |
Options Exercise |
|
|
|
3,169 |
3,169 |
09 Dec 2025 |
Direct |
| Kapil Dhingra |
REPL |
Stock Option (right to buy) |
Options Exercise |
-100% |
|
|
-3,169 |
0 |
09 Dec 2025 |
Direct |
| Sushil Patel |
REPL |
Common Stock |
Sale |
-2.91% |
$111,300 |
$11.13 |
-10,000 |
333,576 |
02 Dec 2025 |
Direct |
| Christopher Sarchi |
REPL |
Common Stock |
Sale |
-4.06% |
$47,393 |
$9.10 |
-5,208 |
123,088 |
17 Nov 2025 |
Direct |
| Konstantinos Xynos |
REPL |
Common Stock |
Sale |
-4.93% |
$65,957 |
$9.10 |
-7,248 |
139,685 |
17 Nov 2025 |
Direct |
| Emily Luisa Hill |
REPL |
Common Stock |
Sale |
-6.38% |
$49,157 |
$5.37 |
-9,154 |
134,368 |
15 Aug 2025 |
Direct |
| Philip Astley-Sparke |
REPL |
Common Stock |
Sale |
-2.25% |
$260,169 |
$8.06 |
-32,279 |
1,405,071 |
20 May 2025 |
Direct |
| Konstantinos Xynos |
REPL |
Common Stock |
Sale |
-5.13% |
$64,093 |
$8.06 |
-7,952 |
146,933 |
20 May 2025 |
Direct |
| Andrew Schwendenman |
REPL |
Common Stock |
Sale |
-4.59% |
$26,460 |
$8.05 |
-3,287 |
68,284 |
20 May 2025 |
Direct |
| Sushil Patel |
REPL |
Common Stock |
Sale |
-6.81% |
$202,346 |
$8.06 |
-25,105 |
343,576 |
20 May 2025 |
Direct |
| Emily Luisa Hill |
REPL |
Common Stock |
Sale |
-1.74% |
$20,407 |
$8.05 |
-2,535 |
143,522 |
20 May 2025 |
Direct |
| Christopher Sarchi |
REPL |
Common Stock |
Sale |
-2.84% |
$30,179 |
$8.05 |
-3,749 |
128,296 |
20 May 2025 |
Direct |
| Veleka Peeples-Dyer |
REPL |
Stock Option (right to buy) |
Award |
|
|
|
32,000 |
32,000 |
01 Apr 2025 |
Direct |
| Sushil Patel |
REPL |
Common Stock |
Award |
82.5% |
|
|
166,667 |
368,681 |
01 Apr 2025 |
Direct |
| Sushil Patel |
REPL |
Employee Stock Option (right to buy) |
Award |
|
|
|
250,000 |
250,000 |
01 Apr 2025 |
Direct |
| Paolo Pucci |
REPL |
Stock Option (right to buy) |
Award |
|
|
|
32,000 |
32,000 |
01 Apr 2025 |
Direct |
| Madhavan Balachandran |
REPL |
Stock Option (right to buy) |
Award |
|
|
|
32,000 |
32,000 |
01 Apr 2025 |
Direct |
| Konstantinos Xynos |
REPL |
Common Stock |
Award |
41% |
|
|
45,000 |
154,885 |
01 Apr 2025 |
Direct |
| Konstantinos Xynos |
REPL |
Employee Stock Option (right to buy) |
Award |
|
|
|
67,500 |
67,500 |
01 Apr 2025 |
Direct |
| Kapil Dhingra |
REPL |
Stock Option (right to buy) |
Award |
|
|
|
32,000 |
32,000 |
01 Apr 2025 |
Direct |
| Joseph P. Slattery |
REPL |
Stock Option (right to buy) |
Award |
|
|
|
32,000 |
32,000 |
01 Apr 2025 |
Direct |
| Emily Luisa Hill |
REPL |
Common Stock |
Award |
44.5% |
|
|
45,000 |
146,057 |
01 Apr 2025 |
Direct |
| Emily Luisa Hill |
REPL |
Employee Stock Option (right to buy) |
Award |
|
|
|
67,500 |
67,500 |
01 Apr 2025 |
Direct |
| Dieter Weinand |
REPL |
Stock Option (right to buy) |
Award |
|
|
|
32,000 |
32,000 |
01 Apr 2025 |
Direct |
| Christopher Sarchi |
REPL |
Common Stock |
Award |
51.7% |
|
|
45,000 |
132,045 |
01 Apr 2025 |
Direct |
| Christopher Sarchi |
REPL |
Employee Stock Option (right to buy) |
Award |
|
|
|
67,500 |
67,500 |
01 Apr 2025 |
Direct |
| Christy J. Oliger |
REPL |
Stock Option (right to buy) |
Award |
|
|
|
32,000 |
32,000 |
01 Apr 2025 |
Direct |
| Andrew Schwendenman |
REPL |
Common Stock |
Award |
-31.8% |
|
|
-33,333 |
71,571 |
01 Apr 2025 |
Direct |
| Andrew Schwendenman |
REPL |
Employee Stock Option (right to buy) |
Award |
|
|
|
50,000 |
50,000 |
01 Apr 2025 |
Direct |